Comparison of outcomes between surgery and chemoradiotherapy after endoscopic resection for pT1a-MM with lymphovascular invasion or pT1b esophageal squamous cell carcinoma: Japanese multicenter propensity score-matched study
Journal of Gastroenterology · 2025
DOI: 10.1007/s00535-024-02188-7 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Gastroenterology, 2025. Verfasst von Yoshinobu Yamamoto und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Oncology, Hyogo Cancer Center, 13-70 Kitaoji-Cho, Akashi, Hyogo, 673-8558, Japan. Hauptthemen laut MEDLINE: Propensity Score, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Neoplasm Invasiveness. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lymphovascular invasion (LVI) or pT1b is noncurative after endoscopic resection (ER) for esophageal squamous cell carcinoma (ESCC), and therefore surgery or chemoradiotherapy (CRT) is recommended. However, there has been debate regarding which treatment has better outcomes and whether individual risks should be considered.
Methods
This was a multicenter, retrospective study conducted at 65 hospitals in Japan. The inclusion criteria were patients with ESCC who underwent ER between January 2006 and December 2015, with pT1a-muscularis mucosa (MM) with LVI or pT1b, with negative vertical margins, cN0M0, and who underwent surgery or CRT. A 1:1 propensity score-matched analysis was performed between two groups. The primary and secondary end points were overall survival (OS) and relapse-free survival (RFS). OS and RFS were also compared between two subgroups: low risk (pT1a-MM with LVI and pT1b without LVI) and high risk (pT1b with LVI) for metastatic recurrence.
Results
Among 472 patients, 160 patients were selected from each group. The OS and RFS did not differ between surgery and CRT groups (hazard ratio, 0.887; P = .635 and hazard ratio, 1.036; P = .876, respectively). Subgroup analysis showed that CRT had a better prognosis in the low-risk group, and conversely, surgery had a better prognosis in the high-risk group. But these were not significant. The high-risk CRT group had a significant worse prognosis than the low-risk CRT group.
Conclusions
In patients with noncurative ER for ESCC, surgery and CRT showed no difference in long-term outcomes. Indications for CRT in the high-risk group need further investigation because of poor prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Oncology, Hyogo Cancer Center, 13-70 Kitaoji-Cho, Akashi, Hyogo, 673-8558, Japan.
- Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan. ryu1486@gmail.com.
- Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
- Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
- Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan.
- Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Zitieren
APA
Yamamoto, Y., Ishihara, R., Kawakubo, H., Nishikawa, M., Yamamoto, S., Kadota, T., Abe, S., Yoshida, M., Tanaka, T., Nagano, H., Nakanishi, H., Yoshizaki, T., Waki, K., Takahashi, A., Kitagawa, Y., Mizuno, K., Kawada, K., Kono, Y., Katada, C., …, & Kitagawa, Y. (2025). Comparison of outcomes between surgery and chemoradiotherapy after endoscopic resection for pT1a-MM with lymphovascular invasion or pT1b esophageal squamous cell carcinoma: Japanese multicenter propensity score-matched study. Journal of Gastroenterology. https://doi.org/10.1007/s00535-024-02188-7
Vancouver
Yamamoto Y, Ishihara R, Kawakubo H, Nishikawa M, Yamamoto S, Kadota T, et al. Comparison of outcomes between surgery and chemoradiotherapy after endoscopic resection for pT1a-MM with lymphovascular invasion or pT1b esophageal squamous cell carcinoma: Japanese multicenter propensity score-matched study. Journal of Gastroenterology. 2025. doi:10.1007/s00535-024-02188-7
BibTeX
@article{Yamamoto2025,
author = {Yamamoto, Yoshinobu and Ishihara, Ryu and Kawakubo, Hirofumi and Nishikawa, Michiko and Yamamoto, Sachiko and Kadota, Tomohiro and Abe, Seiichiro and Yoshida, Masao and Tanaka, Tsutomu and Nagano, Hiroaki and Nakanishi, Hiroyoshi and Yoshizaki, Tetsuya and Waki, Kotaro and Takahashi, Akiko and Kitagawa, Yoshiyasu and Mizuno, Kenichi and Kawada, Kenro and Kono, Yoshiyasu and Katada, Chikatoshi and Hashimoto, Takashi and Nagami, Yasuaki and Yoshio, Toshiyuki and Shimokawa, Toshio and Nihei, Keiji and Koyanagi, Kazuo and Kato, Ken and Yano, Tomonori and Muto, Manabu and Kitagawa, Yuko},
title = {Comparison of outcomes between surgery and chemoradiotherapy after endoscopic resection for pT1a-MM with lymphovascular invasion or pT1b esophageal squamous cell carcinoma: Japanese multicenter propensity score-matched study},
journal = {Journal of Gastroenterology},
year = {2025},
doi = {10.1007/s00535-024-02188-7}
}
EUVIMED